ALKBH5 and intrahepatic cholangiocarcinoma: Similarly, knockdown of ALKBH5 in intrahepatic cholangiocarcinoma (ICC) cells increased m6A modifications in the 3′UTR of PD-L1 mRNA, resulting in its degradation via YTHDF2.